MicroRNAs miR-221 and miR-222: A new level of regulation in aggressive breast cancer

104Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

MicroRNAs (miRNAs) are crucial in the initiation and progression of tumors. A recent study has reported that the miRNAs miR-221 and miR-222 are involved in the promotion of an aggressive basal-like phenotype in breast cancer, functioning downstream of the RAS pathway and triggering epithelial-to-mesenchymal transition. These new insights into the roles of miR-221/222 in breast cancer metastasis, drug resistance and RAS pathways could potentially have applications in medical practice. © 2011 BioMed Central Ltd.

Cite

CITATION STYLE

APA

Shah, M. Y., & Calin, G. A. (2011, August 31). MicroRNAs miR-221 and miR-222: A new level of regulation in aggressive breast cancer. Genome Medicine. https://doi.org/10.1186/gm272

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free